Diagnostic imaging contrast agents with extended blood retention
US7011815B2 · kind B2 · utility
1Cited by
55References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2003 |
| Grant date | Mar 14, 2006 |
| Priority date | — |
| Expiry date | Jan 30, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B6/507
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to contrast agents for diagnostic imaging with prolonged blood retention. In particular, this invention relates to novel compounds that are characterized by an image enhancing moiety (IEM); a protein plasma binding moiety (PPBM); and a blood half-life extending moiety (BHEM). This invention also relates to pharmaceutical compositions comprising these compounds and to methods of using the compounds and compositions for blood half-life extension and contrast enhancement of diagnostic imaging.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.